The INSR gene gives your cells the instructions for the insulin receptor, which helps insulin move sugar from the blood into cells and supports normal growth. If this gene does not work properly, the body may not respond well to insulin, leading to high blood sugar and problems such as darkened skin folds, slow growth, or diabetes. A subset of variants in this gene can influence how severe these changes are, ranging from milder insulin resistance to rare childhood conditions such as Donohue syndrome and Rabson-Mendenhall syndrome.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or managing processes in the body. Some genes hold the code for proteins, which are the working parts of cells. Others mainly regulate when a process happens, where it happens, and how strongly it runs. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
INSRGene function
What if the gene works
The INSR gene makes the insulin receptor, which helps cells respond to insulin. This lets sugar move from blood into cells and supports normal growth and metabolism.
Risk
What if the gene does not work
Variants in the INSR gene can weaken the body's response to insulin, causing a spectrum from milder insulin resistance to severe early growth and blood sugar problems. More disruptive variants often lead to earlier symptoms and more pronounced features.
Treatment
What does that mean for your treatment
Pathogenic variants in the INSR gene can make standard insulin treatment work less well, so some people need much higher insulin doses. In severe INSR-related insulin resistance, recombinant IGF-1 (mecasermin) is a recognized treatment option and can help improve blood sugar control, sometimes alongside metformin or other diabetes medicines based on the person’s response.
Conditions associated with INSR
Gene function
What if the gene works
After you eat, your body needs a quick way to respond to insulin and move fuel where it is needed. The INSR gene provides the instructions for the cell surface receptor that receives insulin's message. This signaling helps cells handle glucose, store energy, and support normal growth.
The INSR gene gives cells a receptor on their surface that can bind insulin. When insulin attaches, it tells the cell that nutrients are available and that it is time to respond.
This signal helps many cells take glucose from the blood and use it or store it for later. In this way, the INSR gene helps control blood sugar and supports steady energy.
Once activated, the receptor passes insulin's message inward through a series of signals inside the cell. These signals help guide energy use, storage, and routine growth and repair.
What is a variant?
A genetic variant is a minor difference in a gene’s DNA sequence. These differences are common and help explain normal variation among people, including differences in appearance, metabolism, and the way the body responds to environmental factors. Many variants do not have any noticeable effect and are part of natural genetic diversity. Sometimes, though, a variant changes how a gene works to a greater extent and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the INSR gene can change the shape of the insulin receptor, reduce how much of it reaches the cell surface, weaken insulin binding, or blunt the signal sent inside the cell. Milder variants may leave some receptor activity, while more severe variants can greatly reduce or nearly abolish signaling. This helps explain how variants in the INSR gene affect insulin receptor function and why associated insulin resistance can range from later, milder forms to severe forms starting in infancy.
How variants are linked to conditions
Pathogenic variants in the INSR gene can cause inherited forms of severe insulin resistance. Well-established INSR gene variants and severe insulin resistance syndromes include Donohue syndrome, Rabson-Mendenhall syndrome, and type A insulin resistance syndrome. Depending on the variant, people may have very high insulin levels, acanthosis nigricans, delayed puberty or features of polycystic ovary syndrome, and diabetes may develop in childhood or early adulthood.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of being human and are widely seen in the general population. Most do not directly affect health and instead reflect normal human variation. For many genes, having a variant associated with a condition points to a potential link rather than a confirmed diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well-understood variant in a particular gene is enough to establish the diagnosis.
Are there things that can increase or change my risk?
For INSR, risk is shaped mainly by the specific gene change and whether one or two copies of the gene are affected, so the chance of developing related insulin resistance is often largely set by genetics. Severity can vary, and factors such as body weight, puberty, and pregnancy may make blood sugar problems more noticeable, but they do not remove the underlying genetic risk.
Inheritance of INSR variants
The inheritance of the INSR gene variants can differ depending on the specific condition and the variant involved. Some INSR-related conditions are inherited in an autosomal recessive pattern, which means a child inherits one altered copy from each parent, while others can follow an autosomal dominant pattern, where one altered copy from either parent may be enough to affect health. With autosomal dominant INSR-related insulin resistance, each child of a parent who carries the variant has a 50% chance of inheriting it. Because the INSR gene is on chromosome 19, these patterns affect people of any sex.
What does my INSR result mean for my family?
INSR results can have different meanings for family members because this gene is linked to more than one inherited insulin resistance condition. In some families, a changed INSR copy can be passed from parent to child, so close relatives may also carry the variant and could consider learning whether they have it. In other families, the condition appears only when both parents are carriers, which can matter for siblings and future children. The family impact depends on the exact INSR variant and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
INSR genetic testing uses a blood sample, saliva, or sometimes a cheek swab to look for variants in the INSR gene. A lab reads the DNA sequence and compares it with the usual version to identify changes that may help explain insulin resistance or support a suspected inherited condition.
When should I consider getting a genetic test?
Testing for changes in the INSR gene may be worth considering if someone has very strong insulin resistance that seems out of proportion to their weight, especially when it starts in childhood or runs in the family. It can also help when doctors suspect a rare inherited condition affecting growth, puberty, or blood sugar control.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains varies depending on the condition and the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work well for one person but less well for another. Small inherited differences can change how a drug is absorbed, broken down, moved through the body, or how strongly the body responds to it. These differences are common and can influence both benefit and the chance of side effects or unusual sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medications. It studies gene-drug patterns to help explain why the same treatment may work differently in different people. For many medicines, genes influence either how strongly a drug works or how the body processes it. This information can support treatment choices that are more informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the INSR gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medicine choices, so general questions about symptoms, blood sugar, or medications are best discussed with your doctor. Research on the INSR gene has looked at whether some changes may affect response to insulin or other diabetes treatments, but this is not used routinely to guide care.
History
Doctors first recognized rare families and children with striking insulin resistance long before the INSR gene itself was identified. In the 1970s, researchers showed that some of these cases were linked to problems with the body’s insulin receptor, which marked a major shift in diabetes and hormone research. Building on this early work, scientists connected severe conditions such as Donohue syndrome and Rabson-Mendenhall syndrome to changes in the receptor pathway. By the mid-1980s, the INSR gene had been cloned and mapped, giving doctors a clearer way to study inherited insulin resistance. This helped move diagnosis from visible features and lab findings toward gene-based confirmation. Over time, descriptions became more precise as more INSR gene variants were identified in affected families.